One of the most heralded oncology conferences is the annual American Society of Clinical Oncologists (ASCO). This year, Chicago is hosting the annual conference, which is running from May 31st through … [Read more...] about ASCO Alert: Stay Ahead of the Updates
Ionis Pharmaceuticals (IONS) has been pushing all-time-highs, which was sparked by a very positive full year 2018 earning report and business update at the end of February. Last week, shares sold off … [Read more...] about INVESTOR ALERT: Upcoming Earnings and Catalyst
Alzheimer disease (AD) is the most common form of dementia. AD is characterized by amyloid plaques and neurofibrillary tangles in the brain, with associated loss of synapses and neurons, … [Read more...] about TAU Me One More Time
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Introduction You may have recently seen hype about Corbus Pharmaceuticals (Nasdaq: CRBP), … [Read more...] about CRBP – Is Corbus Pharmaceuticals a good buy?
Introduction Bristol-Myers Squibb (NYSE: BMY) is a profitable global bio-pharmaceutical company targeting an array of serious diseases and unmet medical needs. Earlier this month BMY announced … [Read more...] about Bristol-Myers Squibb Positioned For Deep Penetration In the Multiple Myeloma Market